A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

NCT02488044 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aeglea Biotherapeutics